Trouble Ahead For This Biotech ETF?

biotechRick Pendergraft:  The biotech sector has had a rough go of it since last July. The SPDR S&P Biotech ETF (NYSEArca: XBI) lost over half of its value from last July’s high to the February low, falling from $90.75 to $44.11.
NASDAQ:IBB April 22, 2016 2:48pm

Big Biotech ETF Faces Key Technical Test

biotechDavid Fabian:  Those who have followed our blog for some time now know that we are big proponents of technical analysis in reading the trends of the market.  This type of examination can also be applied when we are analyzing individual sectors or industries that have diverged from the conventional path of the market.
NASDAQ:BIB March 18, 2016 3:10pm

A More Viable Way To Tap Into Pharmaceutical and Biotech Investing

biotechJJ Feldman:  Tapping into the pharmaceuticals (pharma) and biotechnology sectors can be intimidating, and picking winners in this corner of the health care market is tough.
NYSE:FBT October 13, 2015 4:19pm

Biotech Sector Bounce Looks To Be Coming

biotechRick Pendergraft: The third quarter came to a close yesterday and it wasn’t a good one for the overall market, as the S&P 500 lost 6.94% for its worst quarterly performance in four years.
NASDAQ:BIB October 1, 2015 3:59pm

Biotech ETFs Offer A Great Buying Opportunity Right Now

biotechKyle Anderson:  Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July highs.
NASDAQ:BIB September 29, 2015 3:50pm

Biotech ETF Slide Likely To Continue

biotechRick Pendergraft:  During the first seven months of the year, the biotech sector was among the best performing sectors in the market. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) gained 31.22% from the beginning of the year through the close on July 20.
NASDAQ:BIB September 23, 2015 2:44pm

The Top Biotech ETF To Buy Right Now [First Trust NYSE Arca Biotchnlgy Indx Fd, iShares NASDAQ Biotechnology Index (ETF)]

biotechKyle Anderson: Our favorite biotech ETF has been one of the biggest winners of this sector's 2015 rally…
NASDAQ:BIB June 15, 2015 2:51pm

Changing The Face Of Biotech Investing [iShares NASDAQ Biotechnology Index (ETF), Market Vectors Pharmaceutical ETF]

biotechLawrence Meyers: If you’re interested in seeking out investments in new biotechnology and pharmaceutical advances that could change the face of health care, then you may want to look at some ETFs that may take advantage of the advance in biosimilars.
NASDAQ:IBB June 1, 2015 2:20pm

Pharma’s Record Setting First Quarter [Actavis plc, Allergan, Inc., Eli Lilly and Co, Novartis AG (ADR), AbbVie Inc]

biotechKyle Anderson: The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015.
NYSE:XPH May 12, 2015 12:37pm

Amgen, Inc., Gilead Sciences, Inc., Biogen Inc, Celgene Corporation: Is A Biotech Bubble Looming?

dollar money bubbleJay Taylor: If you own shares of biotechnology stocks, chances are you’re having a great 2015.
NASDAQ:BIB April 14, 2015 2:55pm

Gilead Sciences, Inc., Amgen, Inc., Biogen Inc: Is This A Biotech Bubble?

dollar money bubbleKyle Anderson: Wall Street pundits are claiming we are on the precipice of a biotech bubble because biotechnology stocks have been soaring.
NASDAQ:BIB April 1, 2015 2:55pm

2015 Biotech ETF Surge Reflects Healthy Sector [Novavax, Inc., Biogen Idec Inc, Celgene Corporation, Gilead Sciences, Inc.]

biotechJim Bach: Popular biotech ETF First Trust NYSE Arca Biotechnology Index Fund (NYSE Arca: FBT) is up 23.5% on the year. It's among our top performing picks for year-to-date performance from our "stocks to invest in" list.
NASDAQ:BIB March 23, 2015 12:58pm

The Best Biotech ETF To Buy and One To Avoid [iShares NASDAQ Biotechnology Index (ETF)]

biotechKyle Anderson:  A biotech ETF (exchange-traded fund) is an excellent way to capture profits from the entire industry with just one investment.
NASDAQ:BIB October 14, 2014 3:51pm

Biotechs With Massive Upside [BioCryst Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., AbbVie Inc]

biotechEverybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where a number of players are developing products.
NASDAQ:BIB September 15, 2014 2:08pm

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories